Literature DB >> 18000360

Head and neck cancer: reduce and integrate for optimal outcome.

T J Belbin1, A Bergman, M Brandwein-Gensler, Q Chen, G Childs, M Garg, M Haigentz, R Hogue-Angeletti, R Moadel, A Negassa, R Owen, M B Prystowsky, B Schiff, N F Schlecht, K Shifteh, R V Smith, X Zheng.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18000360     DOI： 10.1159/000108290

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN： 1424-8581            Impact factor:   1.636


× No keyword cloud information.
  7 in total

1.  Proteomics-based Predictive Model for the Early Detection of Metastasis and Recurrence in Head and Neck Cancer.

Authors:  Ilda Patrícia Ribeiro; Luísa Esteves; Sandra Isabel Anjo; Francisco Marques; Leonor Barroso; Bruno Manadas; Isabel Marques Carreira; Joana Barbosa Melo
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

2.  In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages.

Authors:  Tatiana Smirnova; Alfred Adomako; Joseph Locker; Nico Van Rooijen; Michael B Prystowsky; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis.

Authors:  Miriam M Ben-Dayan; Thomas MacCarthy; Nicolas F Schlecht; Thomas J Belbin; Geoffrey Childs; Richard V Smith; Michael B Prystowsky; Aviv Bergman
Journal:  Arch Pathol Lab Med       Date:  2015-07-01       Impact factor: 5.534

4.  Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteins.

Authors:  Thomas M Harris; Peicheng Du; Nicole Kawachi; Thomas J Belbin; Yanhua Wang; Nicolas F Schlecht; Thomas J Ow; Christian E Keller; Geoffrey J Childs; Richard V Smith; Ruth Hogue Angeletti; Michael B Prystowsky; Jihyeon Lim
Journal:  Arch Pathol Lab Med       Date:  2014-10-08       Impact factor: 5.534

5.  Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1.

Authors:  Thomas J Ow; Cory D Fulcher; Carlos Thomas; Pilib Ó Broin; Andrea López; Denis E Reyna; Richard V Smith; Catherine Sarta; Michael B Prystowsky; Nicolas F Schlecht; Bradley A Schiff; Gregory Rosenblatt; Thomas J Belbin; Thomas M Harris; Geoffrey C Childs; Nicole Kawachi; Chandan Guha; Evripidis Gavathiotis
Journal:  Oncotarget       Date:  2019-01-11

6.  Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population.

Authors:  Ashish A Ankola; Richard V Smith; Robert D Burk; Michael B Prystowsky; Catherine Sarta; Nicolas F Schlecht
Journal:  Oral Oncol       Date:  2013-07-25       Impact factor: 5.337

7.  Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.

Authors:  Thomas J Ow; Carlos Thomas; Cory D Fulcher; Jianhong Chen; Andrea López; Denis E Reyna; Michael B Prystowsky; Richard V Smith; Bradley A Schiff; Gregory Rosenblatt; Thomas J Belbin; Thomas M Harris; Geoffrey C Childs; Nicole Kawachi; Nicolas F Schlecht; Evripidis Gavathiotis
Journal:  Laryngoscope       Date:  2020-01-02       Impact factor: 3.325
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.